From Name:
From Email:
To Name:
To Email:

Optional Message:


Investigational monoclonal antibody to treat Ebola is safe in adults, trial indicates

from NIH via Infection Control Today

The investigational Ebola treatment mAb114 is safe, well-tolerated and easy to administer, according to findings from an early stage clinical trial published in The Lancet. Eighteen healthy adults received the monoclonal antibody as part of a phase 1 clinical trial that began in May 2018 at the National Institutes of Health Clinical Center in Bethesda, Maryland. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063